Dosing Time‐Dependent Effect of Raloxifene on Plasma Fibrinogen Concentration in Ovariectomized Rats

References

• Abu‐Fanne R, Brzezinski A, Golomb M, Grad E, Foldes A, Shufaro Y, Varon D, Brill A, Lotan C, Danenberg H. Effects of estradiol and raloxifene on arterial thrombosis in ovariectomized mice. Menopause 2008; 15: 98–104
   PubMed Web of Science ®Google Scholar
• Barrett‐Connor E, Grady D, Sashegyi A, Anderson P W, Cox D A, Hoszowski K, Rautaharju P, Harper K D. Raloxifene and cardiovascular events in osteoporotic postmenopausal women: Four‐year results from the MORE (Multiple Outcomes of Raloxifene Evaluation) randomized trial. JAMA 2002; 287: 847–857, MORE Investigators (Multiple Outcomes of Raloxifene Evaluation)
   PubMed Web of Science ®Google Scholar
• Black L, Sato M, Rowley E, Magee D, Bekele A, Williams D, Cullinan G, Bendele R, Kauffman R, Bensch W, Frolik C A, Termine J D, Bryant H U. Raloxifene (LY139481 HCI) prevents bone loss and reduces serum cholesterol without causing uterine hypertrophy in ovariectomized rats. J. Clin. Invest. 1994; 93: 63–69
   PubMed Web of Science ®Google Scholar
• Bocci V, Viti A. Factors regulating plasma protein synthesis. I. Circadian fluctuations of plasma fibrinogen mass in the rat. Am. J. Physiol. 1971; 221: 719–725
   PubMedGoogle Scholar
• Brosnan J, Sheppard B, Norris L. Haemostatic activation in post‐menopausal women taking low‐dose hormone therapy. Thromb. Haemost. 2007; 97: 558–565
   PubMed Web of Science ®Google Scholar
• Colognesi L, Pasquali V, Foà A, Renzi P, Bernardi F, Bertolucci C, Pinotti M. Temporal variations of coagulation factor VII activity in mice are influenced by lighting regimen. Chronobiol. Int. 2007; 24: 305–313
   PubMed Web of Science ®Google Scholar
• Connerty H, Briggs A. Determination of serum calcium by means of orthocresolphtalein complexone. Am. J. Clin. Pathol. 1966; 45: 290–296
   PubMed Web of Science ®Google Scholar
• Dardente H, Cermakian N. Molecular circadian rhythms in central and peripheral clocks in mammals. Chronobiol. Int. 2007; 24: 195–213
   PubMed Web of Science ®Google Scholar
• Delmas P, Bjarnason N, Mitlak B, Ravoux A, Shah A, Huster W, Draper M, Christiansen C. Effects of raloxifene on bone mineral density, serum cholesterol concentrations, and uterine endometrium in postmenopausal women. N. Engl. J. Med. 1997; 337: 1641–1647
   PubMed Web of Science ®Google Scholar
• Emms H, Lewis G. Sex and hormonal influences on platelet sensitivity and coagulation in the rat. Br. J. Pharmacol. 1985; 86: 557–563
   PubMedGoogle Scholar
• Gallerani M, Boari B, Smolensky M H, Salmi R, Fabbri D, Contato E, Manfredini F. Seasonal variation in occurence of pulmonary embolism: Analysis of the database of the Emilia‐Romagna region, Itlay. Chronobiol. Int. 2007; 24: 143–160
   PubMed Web of Science ®Google Scholar
• Gibaldi M. Prevention and treatment of osteoporosis: Does the future belong to hormone replacement therapy?. J. Clin. Pharmacol. 1997; 37: 1087–1099
   PubMedGoogle Scholar
• Grese T, Sluka J, Bryant H, Cullinan G, Glasebrook A, Jones C, Matsumoto K, Palkowitz A, Sato M, Termine J, Winter M, Yang N, Dodge J. Molecular determinants of tissue selectivity in estrogen receptor modulators. Proc. Natl. Acad. Sci. USA. 1997; 94: 14105–14110
   PubMed Web of Science ®Google Scholar
• Hassan J, Chelucci C, Peschle C, Sorrentino V. Transforming growth factor beta (TGF‐beta) inhibits expression of fibrinogen and factor VII in a hepatoma cell line. Thromb. Haemost. 1992; 67: 478–483
   PubMedGoogle Scholar
• Haus E. Chronobiology of hemostasis and inferences for the chronotherapy of coagulation disorders and thrombosis prevention. Adv. Drug Deliv. Rev. 2007; 59: 966–984
   PubMed Web of Science ®Google Scholar
• Johannes C, Crawford S, Posner J, McKinlay S. Longitudinal patterns and correlates of hormone replacement therapy use in middle‐aged women. Am. J. Epidemiol. 1994; 140: 439–452
   PubMed Web of Science ®Google Scholar
• Joles J, Bijleveld C, van Tol A, Geelen M, Koomans H. Estrogen replacement during hypoalbuminemia may enhance atherosclerotic risk. J. Am. Soc. Nephrol. 1997; 8: 1870–1876
   PubMedGoogle Scholar
• Lakatos P, Blumsohn A, Eastell R, Tarjan G, Shinoda H, Stern P H. Circadian rhythm of in vitro bone‐resorbing activity in human serum. J. Clin. Endocr. Metab. 1995; 80: 3185–3190
   PubMed Web of Science ®Google Scholar
• Manfredini R, Boari B, Smolensky M H, Salmi R, La Cecilia O, Malagoni A M, Haus E, Manfredini F. Circadian variation in stroke onset: Identical temporal pattern in ischemic and hemorrhagic events. Chronobiol. Int. 2005; 22: 417–453
   PubMed Web of Science ®Google Scholar
• Manfredini R, Boari B, Smolensky M H, Salmi R, Gallerani M, Guerzoni F, Guerra V, Malagoni A M, Manfredini F. Seasonal variation in onset of myocardial infarction: A seven‐year single‐center study in Italy. Chronobiol. Int. 2007; 22: 1121–1135
   Google Scholar
• Mrosovsky N, Salmon P. A behavioural method for accelerating re‐entrainment of rhythms to new dark‐light cycles. Nature (Lond). 1987; 330: 372–373
   PubMed Web of Science ®Google Scholar
• Ohkura N, Oishi K, Sakata T, Kadota K, Kasamatsu M, Fukushima N, Kurata A, Tamai Y, Shirai H, Atsumi G, Ishida N, Matsuda J, Horie S. Circadian variations in coagulation and fibrinolytic factors among four different strains of mice. Chronobiol. Int. 2007; 24: 651–669
   PubMed Web of Science ®Google Scholar
• Quigley M. Postmenopausal oestrogen replacement therapy: An appraisal of risks and benefits. Drugs 1981; 22: 153–159
   PubMedGoogle Scholar
• Reitman S, Frankel S. A colorimetric method for the determination of serum glutamic oxalacetic and glutamic pyruvic transaminases. Am. J. Clin. Pathol. 1957; 28: 56–63
   PubMed Web of Science ®Google Scholar
• Sato M, Rippy M, Bryant H. Raloxifene, tamoxifen, nafoxidine, or estrogen effects on reproductive and nonreproductive tissues in ovariectomized rats. FASEB J. 1996; 10: 905–912
   PubMed Web of Science ®Google Scholar
• Seyedin S, Kung V, Danilhoff Y, Hesley R, Gomez B, Nielsen L, Rosen H, Zuk R. Immunoassay for urinary pyridinoline: The new marker of bone resorption. J. Bone Miner. Metab. 1993; 8: 635–642
   Google Scholar
• Shen V, Birchman R, Xu R, Lindsay R, Dempster D W. Short‐term changes in histomorphometric and biochemical turnover markers and bone mineral density in estrogen‐ and/or dietary calcium‐deficient rats. Bone 1995; 16: 149–156
   PubMed Web of Science ®Google Scholar
• Shinoda H, Seto H. Diurnal rhythms in calcium and phosphate metabolism in rodents and their relations to lighting and feeding schedules. Miner. Electrolyte Metab. 1985; 11: 158–166
   PubMedGoogle Scholar
• Shinoda H, Stern P H. Diurnal rhythms in Ca transfer into bone, Ca release from bone, and bone resorbing activity in serum of rats. Am. J. Physiol. 1992; 262: R235–R240
   Google Scholar
• Sugimoto K, Tsuruoka S, Fujimura A. Effect of prolonged nitric oxide synthesis inhibition on plasma fibrinogen concentration in rats. Jpn. J. Pharmacol. 2001; 85: 114–116
   PubMedGoogle Scholar
• Takahashi J, Zatz M. Regulation of circadian rhythmicity. Science (Wash.) 1982; 217: 1104–1111
   PubMed Web of Science ®Google Scholar
• Takamure M, Murakami N, Takahashi K, Kuroda H, Etoh T. Rapid re‐entrainment of the circadian clock itself, but not the measurable activity rhythms to a new light‐dark cycles in the rat. Physiol. Behav. 1991; 50: 443–449
   PubMedGoogle Scholar
• Touitou Y, Smolensky M H, Portaluppi F. Ethics, standards, and procedures of animal and human chronobiology research. Chronobiol. Int. 2006; 23: 1083–1096
   PubMed Web of Science ®Google Scholar
• Tsuruoka S, Sugimoto K, Ohmori M, Kawaguchi A, Saito T, Fujimura A. Chronotherapy of high‐dose 1,25‐dihydroxyvitamin D3 in hemodialysis patients with secondary hyperparathyroidism: A single‐dose study. Clin. Pharmacol. Ther. 1999; 66: 609–616
   PubMed Web of Science ®Google Scholar
• Tsuruoka S, Sugimoto K, Fujimura A. Contribution of the diet to the dosing time‐dependent change of vitamin D3 induced hypercalcemia in rats. Life Sci. 2000; 68: 579–582
   PubMedGoogle Scholar
• Tsuruoka S, Nishiki K, Sugimoto K, Fujimura A. Time of day improves efficacy and reduces adverse reactions of vitamin D3 in 5/6 nephrectomized rat. Life Sci. 2002; 71: 1809–1820
   PubMedGoogle Scholar
• Tsuruoka S, Wakaumi M, Yamamoto H, Fujimura A. Chronopharmacology of oxacalcitriol in rat model of osteoporosis. Eur. J. Pharmacol. 2004; 488: 239–245
   PubMedGoogle Scholar
• Turek F. Circadian neural rhythms in mammals. Ann. Rev. Physiol. 1985; 47: 49–64
   PubMed Web of Science ®Google Scholar
• Walsh B, Kuller L, Wild R, Paul S, Farmer M, Lawrence J, Shah A, Anderson P. Effects of raloxifene on serum lipids and coagulation factors in healthy postmenopausal women. JAMA 1998; 279: 1445–1451
   PubMed Web of Science ®Google Scholar
• Yang N, Venugopalan M, Hardikar S, Glasebrook A. Identification of an estrogen response element activated by metabolites of 17B‐estradiol and raloxfene. Science 1996; 273: 1222–1225
   PubMed Web of Science ®Google Scholar